NCT07445386 Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain
| NCT ID | NCT07445386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Cancer Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-02-16 |
| Primary Completion | 2026-08-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-02-16 with a primary completion date of 2026-08-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the efficacy of fluoroscopy-guided paravertebral (PV) and transdiscal (TD) approaches for splanchnic nerve neurolysis in patients with upper abdominal cancer-related pain (e.g., gastric, pancreatic, and hepatic malignancies). Treatment response will be assessed using the Numerical Rating Scale (NRS), and the impact of both techniques on quality of life will be evaluated with the EORTC QLQ-C30 questionnaire.
Eligibility Criteria
Inclusion Criteria: * Severe abdominal pain (NRS \> 6) due to upper intra-abdominal organ malignancies (such as gastric, pancreatic, or hepatic cancer). * Failure of pain control with conservative treatment modalities. Exclusion Criteria: * Presence of local anatomical variations * Localized or systemic infection involving the procedural site * Pregnancy * Coagulopathy * Presence of unstable psychiatric disorders
Contact & Investigator
Gokhan Yildiz
PRINCIPAL INVESTIGATOR
Ankara Etlik City Hospital
Frequently Asked Questions
Who can join the NCT07445386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07445386 currently recruiting?
Yes, NCT07445386 is actively recruiting participants. Contact the research team at gkoyldz@gmail.com for enrollment information.
Where is the NCT07445386 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07445386 clinical trial?
NCT07445386 is sponsored by Ankara Etlik City Hospital. The principal investigator is Gokhan Yildiz at Ankara Etlik City Hospital. The trial plans to enroll 56 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.